Insider trading · Q3 2026 · CIK 1583648

Palvella Therapeutics, Inc. (PVLA) insider trading.

In Q3 2026, insiders at Palvella Therapeutics, Inc. reported 29 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 22 sales worth $6.2M.

Transactions
29
Purchases (P)
0
Sales (S)
22
Net shares, P minus S
-40,719
Insiders
3
Last filed
2026-09-18

Insiders

InsiderRelationshipTransactionsBuysSales
Goin KathleenOfficer · Chief Operating Officer18012
Jenkins George MDirector909
Kiritsy Christopher PDirector201

Transactions

29 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-16Goin KathleenS (D)1,654$153.240Form 4
2026-09-16Goin KathleenS (D)989$152.361,654Form 4
2026-09-16Goin KathleenS (D)1,659$151.162,643Form 4
2026-09-16Goin KathleenM (A)2,154$7.142,154Form 4
2026-09-16Goin KathleenM (A)2,148$9.084,302Form 4
2026-09-15Jenkins George MS (D)560$151.33160,116Form 4
2026-09-15Jenkins George MS (D)954$149.38160,939Form 4
2026-09-15Jenkins George MS (D)263$150.4160,676Form 4
2026-09-14Jenkins George MS (D)5,632$151.46169,613Form 4
2026-09-14Jenkins George MS (D)6,160$152.12163,453Form 4
2026-09-14Jenkins George MS (D)1,560$153.1161,893Form 4
2026-09-11Jenkins George MS (D)1,274$153.06175,245Form 4
2026-09-11Jenkins George MS (D)4,577$151.72176,519Form 4
2026-09-11Jenkins George MS (D)6,520$150.62181,096Form 4
2026-09-02Kiritsy Christopher PM (A)313$127.2563Form 4
2026-09-02Kiritsy Christopher PS (D)313$157250Form 4
2026-08-19Goin KathleenS (D)102$155.59302Form 4
2026-08-19Goin KathleenS (D)400$153404Form 4
2026-08-19Goin KathleenS (D)1,998$151.8804Form 4
2026-08-19Goin KathleenS (D)1,500$151.392,802Form 4
2026-08-19Goin KathleenM (A)2,148$9.084,302Form 4
2026-08-19Goin KathleenM (A)2,154$7.142,154Form 4
2026-08-19Goin KathleenS (D)302$156.770Form 4
2026-07-15Goin KathleenS (D)1,911$150.250Form 4
2026-07-15Goin KathleenS (D)1,029$149.271,911Form 4
2026-07-15Goin KathleenS (D)840$148.42,940Form 4
2026-07-15Goin KathleenS (D)522$147.143,780Form 4
2026-07-15Goin KathleenM (A)2,148$9.084,302Form 4
2026-07-15Goin KathleenM (A)2,154$7.142,154Form 4

Transaction codes in this quarter

Get PVLA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1583648&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · PVLA company page · Palvella Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Palvella Therapeutics, Inc. (PVLA)?

In Q3 2026, insiders at Palvella Therapeutics, Inc. reported 29 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 22 sales worth $6.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Palvella Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/pvla.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.